前哨淋巴结操作对PSMA PET/CT淋巴结阴性前列腺癌患者隐匿性淋巴结转移的诊断价值
本研究回顾性纳入2016至2022年154例原发、中高危且PSMA PET/CT淋巴结阴性(miN0)的前列腺癌患者,所有患者Briganti列线图评估淋巴结转移风险超过5%,均接受机器人辅助前哨淋巴结操作进行淋巴结分期。前哨淋巴结操作检出84枚(14%)肿瘤阳性淋巴结,中位转移灶大小3 mm(四分位距1-4 mm),55例患者(36%)被重新分类为pN1,Clavien-Dindo 3级或以上并发症发生于1例患者(0.6%)。
要点
- PSMA PET/CT淋巴结阴性的中高危前列腺癌患者中,前哨淋巴结操作使36%重新分类为pN1。
- 检出84枚(14%)肿瘤阳性淋巴结,中位转移灶大小3 mm(四分位距1-4 mm)。
- Clavien-Dindo 3级或以上并发症发生于1例患者(0.6%)。
核心结论
- 前哨淋巴结操作将36%的PSMA PET/CT淋巴结阴性且淋巴结转移风险升高的前列腺癌患者分类为pN1。
研究设计与样本
- 2016至2022年回顾性纳入154例原发、PSMA PET/CT淋巴结阴性(miN0)的前列腺癌患者。
- 所有患者Briganti列线图评估淋巴结转移风险超过5%,均接受机器人辅助前哨淋巴结操作进行淋巴结分期。
主要发现
- 前哨淋巴结操作检出84枚(14%)肿瘤阳性淋巴结,中位转移灶大小3 mm(四分位距1-4 mm)。
- 55例患者(36%)被重新分类为pN1。
- Clavien-Dindo 3级或以上并发症发生于1例患者(0.6%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Our objective was to assess the diagnostic value of the sentinel node (SN) procedure for lymph node staging in primary intermediate- and high-risk prostate cancer patients with node-negative results on prostate-specific membrane antigen PET/CT (miN0). Methods: From 2016 to 2022, 154 patients with primary, miN0 PCa were retrospectively included. All patients had a Briganti nomogram-assessed nodal risk of more than 5% and underwent a robot-assisted SN procedure for nodal staging. The prevalence of nodal metastases at histopathology and the occurrence of surgical complications according to the Clavien-Dindo classification were evaluated. Results: The SN procedure yielded 84 (14%) tumor-positive lymph nodes with a median metastasis size of 3 mm (interquartile range, 1-4 mm). In total, 55 patients (36%) were reclassified as pN1. A complication of Clavien-Dindo grade 3 or higher occured in 1 patient (0.6%). Conclusion: The SN procedure classified 36% of patients with miN0 prostate cancer with an elevated risk of nodal metastases as pN1.
引用
- Duin JJ, de Barros HA, Donswijk ML, et al. The Diagnostic Value of the Sentinel Node Procedure to Detect Occult Lymph Node Metastases in PSMA PET/CT Node-Negative Prostate Cancer Patients. J Nucl Med. 2023. PMID: 37414445. doi:10.2967/jnumed.123.265556
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。